FIELD: biochemistry.
SUBSTANCE: invention relates to biochemistry, biotechnology and genetic engineering, in particular, to a drug for treating hepatic fibrosis based on a mixture of two non-viral plasmid structures. First non-viral plasmid structure is pC4W-HGFopt and comprises a gene, which codes human hepatocyte growth factor. Second is a pVax1-UPAopt and contains a gene coding human urokinase. In said drug plasmid structures are contained in following concentrations: pC4W-HGFopt – from 0.5 to 0.7 mg/ml; pVax1-UPAopt – from 0.3 to 0.5 mg/ml, wherein total concentration of DNA is 1±0.01 mg/ml. Present invention discloses a method of producing said drug and method of treating hepatic fibrosis using said drug in a pharmaceutically acceptable amount.
EFFECT: present invention enables to produce a drug for treating hepatic fibrosis, having higher efficiency, which is safe and easy to produce.
12 cl, 28 dwg, 4 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ANGIOGENESIS AUGMENTATION IN ISCHEMIC TISSUES AND COMBINATION DRUG FOR METHOD IMPLEMENTATION | 2015 |
|
RU2628706C2 |
GENETIC ENGINEERING STRUCTURE FOR STIMULATING POST-TRAUMATIC REGENERATION OF PERIPHERAL NERVES | 2019 |
|
RU2719013C1 |
HGFopt GENE OF HEPATOCYTE GROWTH FACTOR | 2008 |
|
RU2385936C1 |
HC356 DEOXYRIBONUCLEIC ACID SEGMENT, POLYPEPTIDE, ESCHERICHIA COLI STRAIN AS PRODUCER OF POLYPEPTIDE CAPABLE OF BINDING HEPATITIS C VIRUS ANTIBODIES | 1993 |
|
RU2041949C1 |
METALLOPROTEINASE-1 MMP1opt GENE | 2008 |
|
RU2378377C1 |
GENETIC ENGINEERING STRUCTURE FOR ANGIOGENESIS STIMULATION | 2019 |
|
RU2737487C1 |
METHOD FOR STIMULATING RECOVERED PERIPHERAL TISSUE INNERVATION | 2011 |
|
RU2486918C1 |
VEGFopt GENE OF HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR | 2008 |
|
RU2385937C1 |
RECOMBINANT PLASMIN DNA pFGF2, ENCODING A POLYPEPTIDE WITH THE PROPERTIES OF THE MAIN HUMAN FIBROBLAST GROWTH FACTOR AND RECOMBINANT STRAIN OF METHYLOTROPHIC YEAST PICHIA PASTORIS WHICH IS PRODUCER OF POLYPEPTIDE WITH THE PROPERTIES OF THE MAIN FIBROBLAST GROWTH FACTOR | 2021 |
|
RU2804544C2 |
AGENT PROMOTING THERAPEUTIC ANGIOGENESIS AND METHOD FOR IMPLEMENTATION THEREOF | 2009 |
|
RU2449799C2 |
Authors
Dates
2017-04-04—Published
2015-05-07—Filed